Finally, NKG2D, a powerful activating receptor involved in the regulation of immune responses during infection, cancer and autoimmunity [20], was preferentially detected on CD34-lineage- cells cultured with IL-15 and IL-21 (Figure 3). This evidence concerns the gene CD34 and cancer.